tradingkey.logo
tradingkey.logo
Search

Atossa Therapeutics Inc

ATOS
Add to Watchlist
2.070USD
-0.120-5.48%
Close 07-31 16:00ETQuotes delayed by 15 min
17.83MMarket Cap
LossP/E TTM

ATOS Income Statement

You can find the annual or quarterly income statement of Atossa Therapeutics Inc here for insights into the performance and operational efficiency of Atossa Therapeutics Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
FY2014Q2
FY2014Q1
FY2013Q4
FY2013Q3
FY2013Q2
FY2013Q1
FY2012Q4
FY2012Q3
FY2012Q2
FY2012Q1
Total revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
--0.00
--0.00
--0.00
-196853.08%-5.34M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-94.25%2.71K
-95.53%3.43K
-96.97%9.88K
-86.79%24.12K
-52.05%47.21K
-27.45%76.60K
46.16%326.08K
233.87%182.67K
--98.46K
--105.58K
--223.10K
--54.71K
Revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-94.25%2.71K
-95.53%3.43K
-96.97%9.88K
-86.79%24.12K
-52.05%47.21K
-27.45%76.60K
46.16%326.08K
233.87%182.67K
--98.46K
--105.58K
--223.10K
--54.71K
Cost of revenue
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
--0.00
--0.00
---3.24M
----
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
437.45%30.96K
188.20%25.94K
1148.93%222.16K
1978.95%66.46K
--5.76K
--9.00K
--17.79K
--3.20K
Operating expenses
33.13%9.87M
59.92%11.44M
44.89%9.25M
27.23%9.04M
6.22%7.41M
-20.71%7.15M
-14.50%6.38M
-8.83%7.11M
-1.66%6.98M
10.83%9.02M
-8.98%7.47M
18.17%7.79M
49.53%7.10M
68.56%8.14M
59.05%8.21M
-5.84%6.59M
34.45%4.75M
14.25%4.83M
47.02%5.16M
77.95%7.00M
20.22%3.53M
61.48%4.23M
6.39%3.51M
-45.98%3.94M
-27.74%2.94M
24.19%2.62M
-0.36%3.30M
75.88%7.29M
116.83%4.06M
36.08%2.11M
61.00%3.31M
118.46%4.14M
10.03%1.87M
-14.20%1.55M
31.92%2.06M
10.10%1.90M
-26.81%1.70M
152.39%1.80M
-59.44%1.56M
-45.68%1.72M
-28.88%2.33M
-452.06%-3.44M
18.28%3.84M
-0.81%3.17M
34.40%3.27M
-63.15%978.40K
-9.22%3.25M
9.86%3.20M
14.64%2.44M
47.20%2.66M
189.72%3.58M
109.48%2.91M
94.32%2.12M
--1.80M
--1.24M
--1.39M
--1.09M
R&D expenses
14.96%4.78M
80.90%6.16M
57.39%5.37M
54.86%5.50M
10.91%4.16M
-39.81%3.40M
-23.62%3.41M
-4.10%3.55M
6.84%3.75M
13.40%5.65M
-13.43%4.47M
7.92%3.71M
134.02%3.51M
172.95%4.99M
133.89%5.16M
-9.63%3.43M
8.74%1.50M
-22.51%1.83M
32.98%2.21M
129.77%3.80M
46.86%1.38M
162.52%2.36M
-1.49%1.66M
-36.70%1.65M
-35.32%938.62K
5.72%898.02K
18.45%1.68M
77.96%2.61M
208.13%1.45M
291.00%849.42K
91.51%1.42M
78.10%1.47M
-13.47%470.98K
-40.72%217.24K
773.47%742.45K
387.65%824.09K
262.94%544.30K
1053.37%366.46K
-91.04%85.00K
-54.75%168.99K
-73.49%149.97K
94.85%-38.44K
2.79%948.96K
-26.88%373.47K
33.92%565.80K
-299.57%-746.11K
187.49%923.17K
168.89%510.77K
91.88%422.50K
-19.61%373.85K
-41.41%321.11K
-65.02%189.96K
-47.32%220.19K
--465.07K
--548.11K
--543.08K
--417.99K
Depreciation, depletion, and amortization
0.00%4.00K
0.00%4.00K
0.00%4.00K
0.00%4.00K
-20.00%4.00K
-71.43%4.00K
33.33%4.00K
33.33%4.00K
66.67%5.00K
600.00%14.00K
50.00%3.00K
50.00%3.00K
50.00%3.00K
15.27%2.00K
-67.83%2.00K
-65.48%2.00K
-78.39%2.00K
-81.25%1.74K
-50.48%6.22K
-53.23%5.79K
-24.91%9.26K
-25.96%9.26K
-1.46%12.55K
-8.71%12.38K
-11.85%12.33K
-19.39%12.50K
17.40%12.74K
36.01%13.57K
77.81%13.98K
-42.40%15.51K
-62.43%10.85K
-69.87%9.97K
-80.38%7.86K
-64.62%26.92K
-61.39%28.88K
-57.47%33.11K
-49.05%40.09K
-97.09%76.09K
-7.79%74.81K
-9.39%77.84K
-7.29%78.68K
6.99%2.62M
-36.64%81.13K
-32.79%85.91K
-32.16%84.87K
1899.74%2.45M
3.36%128.05K
0.10%127.83K
26.43%125.10K
16.61%122.40K
1352.61%123.89K
1397.40%127.70K
1060.10%98.94K
--104.97K
--8.53K
--8.53K
--8.53K
Operating profit
-33.13%-9.87M
-59.92%-11.44M
-44.89%-9.25M
-27.23%-9.04M
-6.22%-7.41M
20.71%-7.15M
14.50%-6.38M
8.83%-7.11M
1.66%-6.98M
-10.83%-9.02M
8.98%-7.47M
-18.17%-7.79M
-49.53%-7.10M
-68.56%-8.14M
-59.05%-8.21M
5.84%-6.59M
-34.45%-4.75M
-14.25%-4.83M
-47.02%-5.16M
-77.95%-7.00M
-20.22%-3.53M
-61.48%-4.23M
-6.39%-3.51M
45.98%-3.94M
27.74%-2.94M
-24.19%-2.62M
0.36%-3.30M
-75.88%-7.29M
-116.83%-4.06M
-36.08%-2.11M
-61.00%-3.31M
-118.46%-4.14M
-10.03%-1.87M
14.20%-1.55M
-31.92%-2.06M
-10.10%-1.90M
26.81%-1.70M
4.68%-1.80M
59.44%-1.56M
45.68%-1.72M
28.88%-2.33M
-94.05%-1.89M
-18.41%-3.84M
0.50%-3.17M
-35.74%-3.27M
62.59%-975.69K
7.33%-3.25M
-23.35%-3.19M
-24.18%-2.41M
-52.93%-2.61M
-210.01%-3.50M
-121.59%-2.58M
-86.97%-1.94M
---1.71M
---1.13M
---1.17M
---1.04M
Net non-operating interest income (expenses)
Non-operating interest income
-57.08%309.00K
-47.19%442.00K
-43.06%570.00K
-39.89%645.00K
-36.73%720.00K
-32.28%837.00K
-21.43%1.00M
9.16%1.07M
33.88%1.14M
40.94%1.24M
--1.27M
--983.00K
--850.00K
--877.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
305.26%154.00
----
----
----
100.06%38.00
2442.36%1.76M
-100.00%0.00
----
-2799.80%-66.12K
630354.55%69.35K
--48.66K
----
911.98%2.45K
-79.25%11.00
--0.00
--143.00
--242.00
15.22%53.00
-100.00%0.00
-100.00%0.00
--0.00
--46.00
--310.00
--863.00
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
15000.00%151.00
309.94%1.44K
10600.00%749.00
-100.00%0.00
-99.99%1.00
-85.61%352.00
-99.57%7.00
--224.00
--7.76K
--2.45K
--1.61K
Gains from sale of securities
----
----
----
----
----
----
----
----
----
----
----
----
-3.57%-29.00K
---8.00K
--0.00
---85.00K
---28.00K
----
----
----
----
---938.79K
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
---192.82K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
----
--0.00
100.00%0.00
----
----
--0.00
---1.71M
100.00%0.00
----
--0.00
--0.00
---2.99M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
35.78%-461.71K
----
----
----
---718.97K
----
----
----
100.00%0.00
----
----
----
-1468.98%-2.35M
----
----
--0.00
---149.95K
100.00%0.00
--0.00
100.00%0.00
--0.00
---6.08K
--0.00
---23.81K
Other non-operating income (expenses)
-16.67%-28.00K
272.73%57.00K
91.91%-11.00K
-64.71%-28.00K
33.33%-24.00K
-213.79%-33.00K
-288.57%-136.00K
43.33%-17.00K
-800.00%-36.00K
113.06%29.00K
-118.04%-35.00K
-475.00%-30.00K
63.64%-4.00K
-6022.45%-222.00K
603.23%194.00K
122.55%8.00K
-49.84%-11.00K
99.84%-3.63K
-317.25%-38.55K
-219.61%-35.48K
29.49%-7.34K
-193453.01%-2.32M
44.46%17.75K
26.02%29.66K
-15.96%-10.41K
-104.12%-1.20K
11711.54%12.28K
29697.47%23.54K
-15316.95%-8.98K
71.39%29.06K
100.08%104.00
100.05%79.00
59.46%59.00
--16.95K
---128.58K
---152.41K
--37.00
----
----
----
100.00%0.00
----
----
----
---1.42K
----
----
----
----
----
----
----
----
----
----
----
----
Income before tax
-42.74%-9.59M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-55.04%-7.49M
-54.14%-8.01M
5.22%-6.67M
-35.27%-4.79M
35.44%-4.83M
-48.87%-5.20M
-80.21%-7.04M
-20.04%-3.54M
-185.84%-7.48M
-6.24%-3.49M
46.22%-3.91M
27.64%-2.95M
-25.98%-2.62M
0.72%-3.29M
-75.31%-7.26M
-117.31%-4.07M
-4.27%-2.08M
-51.52%-3.31M
-84.81%-4.14M
-10.03%-1.87M
21.03%-1.99M
-1167.23%-2.18M
-30.14%-2.24M
26.81%-1.70M
-28.79%-2.52M
105.42%204.69K
44.83%-1.72M
28.91%-2.33M
41.08%-1.96M
-16.27%-3.77M
2.07%-3.12M
-35.77%-3.27M
-20.60%-3.33M
7.32%-3.25M
-23.39%-3.19M
-24.21%-2.41M
-61.69%-2.76M
-206.27%-3.50M
-121.22%-2.58M
-82.65%-1.94M
---1.71M
---1.14M
---1.17M
---1.06M
Income tax
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
----
--0.00
----
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Income after tax
-42.74%-9.59M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-55.04%-7.49M
-54.14%-8.01M
5.22%-6.67M
-35.27%-4.79M
35.44%-4.83M
-48.87%-5.20M
-80.21%-7.04M
-20.04%-3.54M
-185.84%-7.48M
-6.24%-3.49M
46.22%-3.91M
27.64%-2.95M
-25.98%-2.62M
0.72%-3.29M
-75.31%-7.26M
-117.31%-4.07M
-4.27%-2.08M
-51.52%-3.31M
-84.81%-4.14M
-10.03%-1.87M
21.03%-1.99M
-1167.23%-2.18M
-30.14%-2.24M
26.81%-1.70M
-28.79%-2.52M
105.42%204.69K
44.83%-1.72M
28.91%-2.33M
41.08%-1.96M
-16.27%-3.77M
2.07%-3.12M
-35.77%-3.27M
-20.60%-3.33M
7.32%-3.25M
-23.39%-3.19M
-24.21%-2.41M
-61.69%-2.76M
-206.27%-3.50M
-121.22%-2.58M
-82.65%-1.94M
---1.71M
---1.14M
---1.17M
---1.06M
Net income from continuous operations
-42.74%-9.59M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-55.04%-7.49M
-54.14%-8.01M
5.22%-6.67M
-35.27%-4.79M
35.44%-4.83M
-48.87%-5.20M
-80.21%-7.04M
-20.04%-3.54M
-185.84%-7.48M
-6.24%-3.49M
46.22%-3.91M
27.64%-2.95M
-25.98%-2.62M
0.72%-3.29M
-75.31%-7.26M
-117.31%-4.07M
-4.27%-2.08M
-51.52%-3.31M
-84.81%-4.14M
-10.03%-1.87M
21.03%-1.99M
-1167.23%-2.18M
-30.14%-2.24M
26.81%-1.70M
-28.79%-2.52M
105.42%204.69K
44.83%-1.72M
28.91%-2.33M
41.08%-1.96M
-16.27%-3.77M
2.07%-3.12M
-35.77%-3.27M
-20.60%-3.33M
7.32%-3.25M
-23.39%-3.19M
-24.21%-2.41M
-61.69%-2.76M
-206.27%-3.50M
-121.22%-2.58M
-82.65%-1.94M
---1.71M
---1.14M
---1.17M
---1.06M
Net income from discontinued operations
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
100.00%0.00
----
100.00%0.00
100.00%0.00
-20.71%-3.00M
---544.80K
---23.44K
---61.20K
---2.49M
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to controlling interests
-42.74%-9.59M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-55.04%-7.49M
-54.14%-8.01M
5.22%-6.67M
-35.27%-4.79M
59.69%-4.83M
-48.87%-5.20M
-80.21%-7.04M
-20.04%-3.54M
-357.83%-11.99M
-6.24%-3.49M
46.22%-3.91M
27.64%-2.95M
-25.98%-2.62M
0.72%-3.29M
53.51%-7.26M
-117.31%-4.07M
-4.27%-2.08M
-51.52%-3.31M
-224.80%-15.62M
-10.03%-1.87M
21.03%-1.99M
-1167.23%-2.18M
-179.24%-4.81M
26.81%-1.70M
49.14%-2.52M
104.74%204.69K
45.24%-1.72M
30.21%-2.33M
14.65%-4.96M
-33.05%-4.32M
1.34%-3.15M
-38.31%-3.34M
-110.79%-5.81M
7.32%-3.25M
-23.39%-3.19M
-24.21%-2.41M
-61.69%-2.76M
-206.27%-3.50M
-121.22%-2.58M
-82.65%-1.94M
---1.71M
---1.14M
---1.17M
---1.06M
Preferred share dividend
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--4.50M
----
----
----
--0.00
--0.00
-100.00%0.00
----
--0.00
----
346.99%11.48M
----
--0.00
--0.00
--2.57M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net income attributable to common shareholders
-42.74%-9.59M
-72.32%-10.94M
-20.22%-8.69M
-39.25%-8.42M
-14.29%-6.72M
18.15%-6.35M
-16.07%-7.23M
38.46%-6.05M
6.42%-5.88M
-3.51%-7.75M
22.24%-6.23M
-47.33%-9.83M
-31.24%-6.28M
-55.04%-7.49M
-54.14%-8.01M
5.22%-6.67M
-35.27%-4.79M
59.69%-4.83M
-48.87%-5.20M
-80.21%-7.04M
-20.04%-3.54M
-357.83%-11.99M
-6.24%-3.49M
46.22%-3.91M
27.64%-2.95M
-25.98%-2.62M
0.72%-3.29M
53.51%-7.26M
-117.31%-4.07M
-4.27%-2.08M
-51.52%-3.31M
-224.80%-15.62M
-10.03%-1.87M
21.03%-1.99M
-1167.23%-2.18M
-179.24%-4.81M
26.81%-1.70M
49.14%-2.52M
104.74%204.69K
45.24%-1.72M
30.21%-2.33M
14.65%-4.96M
-33.05%-4.32M
1.34%-3.15M
-38.31%-3.34M
-110.79%-5.81M
7.32%-3.25M
-23.39%-3.19M
-24.21%-2.41M
-61.69%-2.76M
-206.27%-3.50M
-121.22%-2.58M
-82.65%-1.94M
---1.71M
---1.14M
---1.17M
---1.06M
Basic earnings per share
-2038.28%-1.11
-2433.61%-1.27
-1656.00%-1.01
-35.54%-0.07
-10.90%-0.05
19.00%-0.05
-16.07%-0.06
38.03%-0.05
5.44%-0.05
-4.61%-0.06
21.73%-0.05
-47.33%-0.08
-31.22%-0.05
-55.19%-0.06
-54.05%-0.06
9.00%-0.05
1.07%-0.04
94.67%-0.04
88.04%-0.04
86.38%-0.06
88.16%-0.04
-149.84%-0.72
4.55%-0.34
46.58%-0.43
47.97%-0.32
21.50%-0.29
43.64%-0.36
84.34%-0.80
12.22%-0.62
64.70%-0.36
69.77%-0.64
34.17%-5.08
86.91%-0.71
87.06%-1.03
-360.06%-2.11
3.34%-7.72
53.95%-5.40
72.09%-7.99
102.89%0.81
60.95%-7.99
51.35%-11.72
32.79%-28.62
-17.92%-28.07
12.94%-20.45
-35.54%-24.09
-53.09%-42.58
40.21%-23.81
25.21%-23.49
31.73%-17.78
-45.33%-27.82
-117.80%-39.82
-68.16%-31.40
-53.21%-26.04
---19.14
---18.28
---18.68
---17.00
Diluted earnings per share
-2038.28%-1.11
-2433.61%-1.27
-1656.00%-1.01
-35.54%-0.07
-10.90%-0.05
19.00%-0.05
-16.07%-0.06
38.03%-0.05
5.44%-0.05
-4.61%-0.06
21.73%-0.05
-47.33%-0.08
-31.22%-0.05
-55.19%-0.06
-54.05%-0.06
9.00%-0.05
1.07%-0.04
94.67%-0.04
88.04%-0.04
86.38%-0.06
88.16%-0.04
-149.84%-0.72
4.55%-0.34
46.58%-0.43
47.97%-0.32
21.50%-0.29
43.64%-0.36
84.34%-0.80
12.22%-0.62
64.70%-0.36
69.77%-0.64
34.17%-5.08
86.91%-0.71
87.06%-1.03
-360.06%-2.11
3.34%-7.72
53.95%-5.40
72.09%-7.99
102.89%0.81
60.95%-7.99
51.35%-11.72
32.79%-28.62
-17.92%-28.07
12.94%-20.45
-35.54%-24.09
-53.09%-42.58
40.21%-23.81
25.21%-23.49
31.73%-17.78
-45.33%-27.82
-117.80%-39.82
-68.16%-31.40
-53.21%-26.04
---19.14
---18.28
---18.68
---17.00
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Atossa Therapeutics Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing ATOS stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Atossa Therapeutics Inc's net income for the year?

Atossa Therapeutics Inc posted -34.77M in net income for fiscal year 2025.

How much net income did Atossa Therapeutics Inc post in the last quarter?

Atossa Therapeutics Inc reported -9.59M in net income for the latest quarter。

What was Atossa Therapeutics Inc's annual operating profit?

Atossa Therapeutics Inc's operating income was -37.14M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.